BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Afferent Pharmaceuticals is defunct.

Fate: Bought by Merck, July 2016, $1.25B


------------------
If you believe any of this information is incorrect, please let us know.